Effect of angiotensin receptor neprilysin inhibitors on left atrial remodeling and prognosis in heart failure

Effect of angiotensin receptor neprilysin inhibitors on left atrial remodeling and prognosis in heart failure

Abstract Aims The angiotensin receptor–neprilysin inhibitor (ARNI), sacubitril/valsartan, confers additional protective effects compared with angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers (ACEIs/ARBs) in terms of reversed left ventricular (LV) remodelling and improves the...

Full description

Bibliographic Details
Main Authors: Yuxi Sun, Shuang Song, Yanli Zhang, Wenqiong Mo, Xinxin Zhang, Ning Wang, Yunlong Xia, Gary Tse, Ying Liu
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:ESC Heart Failure
Subjects:
Sacubitril/valsartan
Left atrium remodelling
Heart failure
Mortality
Online Access:https://doi.org/10.1002/ehf2.13691

Internet

https://doi.org/10.1002/ehf2.13691

Similar Items